Biohaven Ltd. (BHVN) expanding its growth trajectory ahead

Biohaven Ltd. (NYSE: BHVN) stock fell -1.60% on Friday to $19.10 against a previous-day closing price of $19.41. With 2.82 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.94 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $19.50 whereas the lowest price it dropped to was $18.73. The 52-week range on BHVN shows that it touched its highest point at $26.64 and its lowest point at $5.54 during that stretch. It currently has a 1-year price target of $27.20. Beta for the stock currently stands at 7.21.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of BHVN was up-trending over the past week, with a rise of 3.08%, but this was down by -3.92% over a month. Three-month performance dropped to -21.85% while six-month performance rose 32.18%. A look at the trailing 12-month EPS for BHVN yields -6.31 with Next year EPS estimates of -4.86. For the next quarter, that number is -1.34. This implies an EPS growth rate of -151.80% for this year and 3.00% for next year.

Float and Shares Shorts:

At present, 68.25 million BHVN shares are outstanding with a float of 55.19 million shares on hand for trading. On Aug 30, 2023, short shares totaled 5.25 million, which was 7.68% higher than short shares on Jul 30, 2023. In addition to BVN as the firm’s Buenaventura Mining Company Inc, BHVN serves as its Biohaven Ltd.

Institutional Ownership:

Through their ownership of 100.97% of BHVN’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 59.88% of BHVN, in contrast to 30.32% held by mutual funds. Shares owned by individuals account for 14.81%. As the largest shareholder in BHVN with 8.23% of the stake, 1919 Investment Counsel LLC holds 5,618,947 shares worth 5,618,947. A second-largest stockholder of BHVN, Janus Henderson Investors US LLC, holds 5,283,999 shares, controlling over 7.74% of the firm’s shares. Fidelity Management & Research Co is the third largest shareholder in BHVN, holding 3,907,686 shares or 5.72% stake. With a 3.97% stake in BHVN, the Fidelity Select Port. – Biotechno is the largest stakeholder. A total of 2,714,104 shares are owned by the mutual fund manager. The SPDR S&P Biotech ETF, which owns about 2.40% of BHVN stock, is the second-largest Mutual Fund holder. It holds 1,636,567 shares valued at 29.93 million. Janus Henderson Global Life Scien holds 2.04% of the stake in BHVN, owning 1,393,044 shares worth 25.48 million.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2023, BHVN reported revenue of $0.00 and operating income of -$197.11M. The EBITDA in the recently reported quarter was -$196.69M and diluted EPS was -$5.67.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for BHVN since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With BHVN analysts setting a high price target of $31.00 and a low target of $23.00, the average target price over the next 12 months is $27.00. Based on these targets, BHVN could surge 62.3% to reach the target high and rise by 20.42% to reach the target low. Reaching the average price target will result in a growth of 41.36% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.

Summary of Insider Activity:

Insiders traded BHVN stock several times over the past three months with 1 Buys and 0 Sells. In these transactions, 100,000 shares were bought while 0 shares were sold. The number of buy transactions has increased to 102 while that of sell transactions has risen to 10 over the past year. The total number of shares bought during that period was 51,944,239 while 36,068,162 shares were sold.

Leave a Comment

Your email address will not be published. Required fields are marked *